Suggestions
Joshua McClure
CEO @ Maxwell Biosciences - developing broad spectrum biodefense biotechnology effective against viruses, fungi and bacteria with a single molecule. One drug 💥 Many bugs.
Joshua "Scotch" McClure is the CEO and Co-founder of Maxwell Biosciences, a preclinical drug platform company focused on developing biomimetic therapeutics.12 He is an engineer with over 20 years of experience as a CEO and 10 years of experience as a corporate board director.4 McClure founded Maxwell Biosciences in 2016.1
Under McClure's leadership, Maxwell has grown from a startup to a company heading into FDA clinical trials, working with large corporations to develop innovative anti-infective coatings, and developing new drugs with the US Army to fight Ebola and other dangerous pathogens.1 The company's CLAROMER™ drug platform has shown promising results against various pathogens, including viruses, bacteria, and fungi.3
McClure is a multi-patent inventor, including anti-viral applications of Maxwell's platform.5 He has led the company in raising approximately $47 million from government entities and $27 million in investor support.3
In 2024, J. Scotch McClure was named to The Healthcare Technology Report's list of the Top 25 Executives in Biotechnology1, recognizing his accomplishments in the biotech industry.
Highlights
🐮 Breaking News: H5N1 Detected in US Dairy Cows
The US Department of Agriculture (USDA) has confirmed the presence of the H5N1 virus in dairy cows within Texas and Kansas. The bird flu was identified in unpasteurized milk from cows showing symptoms at two farms in Kansas and one in Texas, with further detections in nose and throat swabs at an additional Texas farm. Preliminary findings suggest a possible infection rate of up to 10% in the cattle populations of these farms. The situation is exacerbated by the discovery of deceased wild birds on the premises, hinting at potential vectors for disease transmission.
Laboratory analysis of the clinical milk samples revealed significant abnormalities, including a thick, syrupy consistency. Despite the effective neutralization of the virus through pasteurization processes, which ensures the safety of milk for consumption, the USDA has opted to either divert or destroy milk from the impacted dairies as a precaution. The Animal and Plant Health Inspection Service (APHIS) has not identified any mutations in the virus that would suggest increased transmissibility to humans. In response to the outbreak, the Texas Agriculture Commissioner has advised against the depopulation of the affected herds at this time, indicating controlled management of the situation.
This incident underscores the critical importance of developing broad spectrum, extremely affordable antivirals. Maxwell Biosciences is working in collaboration with the US Army and other government entities on doing that. You can learn more at MaxwellBiosciences.com.
https://lnkd.in/grZwXMWJ
